References
- 1. Wilde H, Khawplod P, Khamoltham T, Hemachudha T, Tepsumethanon V, Lumlerdacha B, et al. rabies control in South and Southeast Asia. Vaccine. 2005; 23: 2284-9.10.1016/j.vaccine.2005.01.030
- 2. Knobel DL, Cleaveland S, Coleman PG, F☐vre EM, Meltzer MI, Miranda ME, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull WHO. 2005; 83:360-8.
- 3. Burney MI, Khan ZH, Lari FA. The rabies problem in Pakistan. Trop Doct. 1976; 6:60-2.10.1177/004947557600600206
- 4. Dodet B, Goswami A, Gunasekera A. Rabies awareness in eight Asian countries. Vaccine. 2008; 26:6344-8.10.1016/j.vaccine.2008.09.003
- 5. Parviz S, Chotani R, McCormick J, Fisher-Hoch S, Luby S. Rabies deaths in Pakistan: results of ineffective post-exposure treatment. Int J Infect Dis. 2004; 8:346-52.10.1016/j.ijid.2004.02.008
- 6. Parviz S, Luby S, Wilde H. Postexposure treatment of rabies in Pakistan. Clin Infect Dis. 1998; 27:751-6.10.1086/514931
- 7. Salahuddin N, Jamali S, Ibraheem K, Sardar S. Awareness about rabies post exposure prophylaxis in Pakistan among patients and health care workers: results from an Asian Rabies Expert Bureau study. J Coll Physicians Surg Pak. 2011; 21:491-4.
- 8. World Health Organization. WHO International Expert Consultation on Rabies; WHO Geneva. 2012.
- 9. Champion JM, Kean RB, Rupprecht CE, Notkins AL, Koprowski H, Dietzschold B, Hooper DC. The development of monoclonal human rabies virusneutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. J Immun Methods. 2000; 235: 81-90.
- 10. Nagarajan T, Rupprecht CE, Dessain SK, Rangarajan PN, Thiagarajan D, Srinivasan VA. Human monoclonal antibody and vaccine approaches to prevent human rabies. Curr Top Microbiol Immunol. 2008; 317:67-101.